Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05884216 · ClinicalTrials.gov registry record · NA
Entarik Feeding Tube System Placement in Adult ICU
A NA study, sponsored by Gravitas Medical.
- Terminated
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT05884216: Clinical Trial NA study, sponsored by Gravitas Medical.
NCT05884216 is a NA study that was terminated before completion, run by Gravitas Medical. The registered enrollment target is 45 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05884216, a NA study, was terminated before completion, sponsored by Gravitas Medical.
- TERMINATED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and effectiveness of the Entarik Feeding Tube System in an adult ICU patient population for the administration of nutrition, fluids and medications.
Primary Outcome
All patients will receive placement verification per institutional standard of care.
Interventions
- DEVICE Entarik Feeding Tube System
- DEVICE Entarik Feeding Tube System without monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2023-05-30 |
| Est. Completion | 2025-01-23 |
| Phase | NA |
Why NCT05884216 stopped before completion
NCT05884216 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Entarik Feeding Tube System is the first listed.
NCT05884216 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05884216 about?
NCT05884216 is a clinical study titled "Entarik Feeding Tube System Placement in Adult ICU". The purpose of this study is to evaluate the safety and effectiveness of the Entarik Feeding Tube System in an adult ICU patient population for the administration of nutrition, fluids and medications.
What is the current status of trial NCT05884216?
This trial is currently terminated. It is a NA study. The enrollment target is 45 participants. The study started on 2023-05-30. Estimated completion is 2025-01-23.
What interventions are being tested in trial NCT05884216?
The interventions under investigation include: Entarik Feeding Tube System (DEVICE), Entarik Feeding Tube System without monitoring (DEVICE).
Who is sponsoring clinical trial NCT05884216?
This trial is sponsored by Gravitas Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05884216's enrollment target sits among peer trials
45 1411th of 2000 higher than 578 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI